Results 241 to 250 of about 235,837 (357)

2024 multidisciplinary consensus on image-guided lung tumor ablation from the Taiwan Academy of Tumor Ablation. [PDF]

Thorac Cancer
Chang LK, Yang SM, Chien N, Chang CC, Fang HY, Liu MC, Wang KL, Lin WC, Lin FCF, Chuang CY, Hsu PK, Huang TW, Chen CK, Chang YC, Huang KW.   +14 more
europepmc   +1 more source

Percutaneous Magnetic Resonance Imaging-Guided Focal Laser Ablation (MRI-FLA) of Prostate Tumors: A Systematic Review and Network Meta-Analysis [PDF]

Clément Marcelin, Clément Klein, G. Robert, Franck Bladou, N. Grenier, Eva Jambon   +5 more
openalex   +1 more source

Exon 7 splicing of ERα predicts poor prognosis and increases phenotypic heterogeneity in luminal a subtype breast cancer

FEBS Open Bio, EarlyView.
ERα splice variant ERα∆7 lacks the C‐terminus, and its expression may change phenotypes of breast cancers. Our results showed that ERα∆7 is found in the luminal A subtype, and elevated ERα∆7 levels are linked to improved cell survival with lower proliferation and migration.
Long Wai Tsui, Taobo Hu, Thomson Christian Husein, Wai Hei Shek, Bingrong Chen, Depeng Wang, Shu Wang, Weichuan Yu, Xiaodan Fan, Mengping Long, Toyotaka Ishibashi   +10 more
wiley   +1 more source

Two-dimensional nanomaterials for bone disease therapy: multifunctional platforms for regeneration, anti-infection and tumor ablation. [PDF]

J Nanobiotechnology
Cai X, Lv Z, Wang Z, Wang Y, Xu J, Yang X, Wang H, Bian Y, Zhu Y, Feng B, Weng X.   +10 more
europepmc   +1 more source

Development of human monoclonal antibodies against TARM1 by yeast display

FEBS Open Bio, EarlyView.
Human monoclonal antibodies against TARM1 are generated by yeast display‐guided selection. These antibodies bind to soluble and cell‐surface forms of TARM1. Also, these antibodies exhibit agonistic activity in the NFAT‐GFP reporter assay, indicating that TARM1 signaling can be functionally modulated by antibodies and suggesting TARM1 as a potential ...
Rikio Yabe, Mayumi Saeki, Masaaki Hashiguchi, Sayaka Ono, Kazuhisa Aoki, Hidetaka Tanno   +5 more
wiley   +1 more source

Biomolecule-tailored chiral nickel oxide nanozymes amplify autophagy-mediated tumor ablation via synergistic photodynamic-chemodynamic therapy. [PDF]

Mater Today Bio
Pang W, Shao Y, Xu H, Li T, Wu L, Liu Z, Zhang L, Chen W, Li Y, Xu D, Cheng J, Xu X.   +11 more
europepmc   +1 more source

Screening and epitope characterization of Nidogen‐2‐specific nanobodies

FEBS Open Bio, EarlyView.
Camel immunization and phage display were employed to generate high‐affinity VHH nanobodies against Nidogen‐2. After library construction, biopanning, ELISA screening, sequencing, and recombinant expression, selected nanobodies were purified and characterized, leading to the preliminary exploration of a nanobody‐based sandwich ELISA for specific ...
Jianchuan Wen, Qianqian Cui, Zhongyun Lan, Yingjun Wang, Shuaiying Zhao, Wenxuan Feng, Yunfeng Liu, Qiting Huang, Dongna Zhang, Jianfeng Xu   +9 more
wiley   +1 more source

Synergizing photodynamic therapy and ethanol ablation: Light-activatable sustained-exposure ethanol injection technology for enhanced tumor ablation. [PDF]

Bioeng Transl Med
Ma CH, Yang J, Quinlan JA, McNaughton K, Kaluzienski ML, Hauser T, Starost MF, Mueller JL, Huang HC.   +8 more
europepmc   +1 more source

3DMesoporous Electrodes Integrated with Soft SurgicalRobotics for Putative Minimally Invasive Intraoperative Tumor Detectionand Ablation Monitoring

Yulin Qiu (22059911), Aditya Ashok (11355215), Chi Cong Nguyen (20500798), Eva Tomaskovic-Crook (2474689), Michael A. Listyawan (22059914), Thanh-An Truong (13153328), Kefan Zhu (22059917), Hongru Chen (811260), Mohit N. Shivdasani (14754304), Thanh Nho Do (13153343), Yusuke Yamauchi (1410556), Jeremy M. Crook (9133361), Hoang-Phuong Phan (4355992)   +12 more
openalex   +1 more source

Dynamic Contrast-Enhanced MR Imaging in Detecting Local Tumor Progression after HIFU Ablation of Localized Prostate Cancer

, 2013
Jung Jae Park, Chan Kyo Kim, Hyun Moo Lee, Byung Kwan Park, Sung Yoon Park   +4 more
openalex   +1 more source